Effector mechanisms in low-dose streptozotocin-induced diabetes

Dev Immunol. 1998;6(1-2):119-28. doi: 10.1155/1998/92198.

Abstract

The cellular and molecular requirements for beta-cell damages in an immune-mediated toxin-induced insulin-dependent diabetes mellitus have been studied in the model of multiple low-dose streptozotocin-induced diabetes in rats and mice. It was found that strain-related susceptibility to diabetes induction correlated with a higher level of IL-2, IFN-gamma, and TNF-alpha production, whereas such differences were not observed when IL-1 and NO production by macrophages were analyzed; elimination of immunoregulatory RT6+T cells that increases IFN-gamma production, enhances susceptibility to MLD-STZ-induced diabetes; mercury-induced Th-2 cells down-regulated the disease; IFN-gamma-mediated macrophage activation to produce proinflammatory cytokines rather than NO is an important event in early diabetogenic effects of invading macrophages; inhibition of IL-1 activity downregulates diabetes induction; and generation of NO in beta cells appears to be important for diabetogenic effects. Taken together, data indicate that MLD-STZ diabetes induced by Th-1 lymphocytes that secrete soluble effector molecules that activate macrophages and promote destruction of beta cells possibly by both nitric oxide and nonnitric oxide-mediated mechanisms.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Diabetes Mellitus, Experimental / immunology*
  • Interferon-gamma / physiology
  • Interleukin-1 / pharmacology
  • Islets of Langerhans / pathology
  • Macrophages / physiology
  • Mice
  • Nitric Oxide / biosynthesis
  • Rats
  • Streptozocin

Substances

  • Interleukin-1
  • Nitric Oxide
  • Streptozocin
  • Interferon-gamma